A detailed history of Buckingham Capital Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 64,078 shares of NVO stock, worth $5.3 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
64,078
Previous 32,535 96.95%
Holding current value
$5.3 Million
Previous $3.87 Million 42.29%
% of portfolio
0.65%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$85.0 - $120.04 $2.68 Million - $3.79 Million
31,543 Added 96.95%
64,078 $5.51 Million
Q3 2024

Nov 04, 2024

BUY
$119.07 - $145.42 $3.87 Million - $4.73 Million
32,535 New
32,535 $3.87 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $187B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Buckingham Capital Management, Inc. Portfolio

Follow Buckingham Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.